Baird Medical Investment Holdings Ltd. (BDMD) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$0.09

From 52W high−96.98%

Volume3.91M

Market cap$3.33M

P/E (TTM)—

P/S (TTM)0.1x

Div yield—

Key dataNov 4, 2026

Open

$0.09

From 52W high

−96.98%

Volume

3.91M

Market cap

$3.33M

ValuationView details →

P/E (Fwd)

1.3x

EV/EBITDA

−1.3x

P/E (TTM)

—

RSI (14)

12.6

MomentumView details →

1D Return

−11.20%

YTD Return

−92.59%

SummaryUpdated Jun 1, 2026

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) is a Chinese medical device company that went public in December 2021. Founded in 2012 and headquartered in Guangzhou, China, the company specializes in developing and manufacturing microwave ablation systems for minimally invasive tumor treatment. Baird Medical has established itself as a focused player in the oncology medical device market, primarily serving the Chinese healthcare system with its proprietary microwave ablation technology for treating various types of benign and malignant tumors.

Ask drillr about Baird Medical Investment Holdings Ltd. →

ValuationView details →

P/E (Fwd)

1.3x

P/E (TTM)

—

EV/EBITDA

−1.3x

EV/Sales

0.7x

P/S (TTM)

0.1x

P/B (TTM)

0.1x

ProfitabilityView details →

Gross Margin

85.63%

Net Margin

−65.12%

EBITDA Margin

−53.18%

ROE (TTM)

−45.86%

ROA (TTM)

−21.60%

Asset Turnover

0.34x

GrowthView details →

Revenue YoY

−23.12%

EPS YoY

—

FCF YoY

+154.11%

Revenue CAGR 3Y

−13.72%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−11.20%

YTD Return

−92.59%

1Y Return

−91.38%

RSI (14)

12.6

vs 50D SMA

−86.56%

vs 200D SMA

−92.37%

Capital & dividendView details →

Debt/Equity

0.41x

Current Ratio

1.29x

Quick Ratio

1.26x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.04

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

$0.08

Avg Surprise (4Q)

0.00%

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

56.35M

Net Income (TTM)

−19.12M

Op. CF (TTM)

−1.24M

Latest newsMore news →

Baird Medical and Alpmed signed a strategic cooperation agreement to establish a long-term partnership for global development and commercialization of next-generation irreversible electroporation (IRE) technologies.86d ago

Similar companies

20/20 Biolabs, Inc. Common StockAIDX Autonomix Medical, Inc. Common StockAMIX Inspira Technologies Oxy B.H.N. Ltd.IINNW Vivos Therapeutics, Inc.VVOS Beyond Air, Inc.XAIR IceCure Medical LtdICCM Find similar companies →

Latest newsMore news →

Baird Medical's PRC subsidiary G-Resources Group Ltd. entered into an exclusive distribution agreement with China Resources Pharmaceutical Group Ltd. for Baird's microwave ablation products in 19 PRC markets, including an initial purchase order of RMB 6 million ($900,000).2d ago Baird Medical and Alpmed signed a strategic cooperation agreement to establish a long-term partnership for global development and commercialization of next-generation irreversible electroporation (IRE) technologies.86d ago